Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-77633-5_26PMID 1490357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of nuclear c-MYC oncoprotein expression in human hematopoiesis: suitability of a rapid and reliable semiquantitative evaluation system.

  1992cited by this paper
• Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells.

  1992cited by this paper
• Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

  1992cited by this paper
• c-myc reverses neu-induced transformed morphology by transcriptional repression

  1991cited by this paper
• Myc protein structure: localization of DNA-binding and protein dimerization domains.

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.

  1991cited by this paper
• myc family oncogenes in the development of normal and neoplastic cells.

  1991cited by this paper
• Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.

  1991cited by this paper
• Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.

  1991cited by this paper
• Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

  1991cited by this paper
• Are myc proteins transcription factors?

  1990cited by this paper
• A transcriptional repressor of c-myc

  1989cited by this paper
• Once-lame duck now exudes self-confidence

  1989cited by this paper
• A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation

  1989cited by this paper
• Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.

  1989cited by this paper
• Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot study.

  1989cited by this paper
• The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation.

  1989cited by this paper
• Detection of oncogene expression by fluorescent in situ hybridization in combination with immunofluorescent staining of cell surface markers.

  1989cited by this paper
• In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies.

  1989cited by this paper
• Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.

  1989cited by this paper
• Ras oncogene mutation in multiple myeloma

  1989cited by this paper
• Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

  1989cited by this paper
• Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.

  1988cited by this paper
• Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma.

  1988cited by this paper
• abl oncogene expression in non‐Hodgkin lymphomas: Correlation to histological differentiation and clinical status

  1988cited by this paper
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

  1988cited by this paper
• L-myc cooperates with ras to transform primary rat embryo fibroblasts

  1988cited by this paper
• Complex translocation disrupts c-myc regulation in a human plasma cell myeloma

  1988cited by this paper
• Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human.

  1988cited by this paper
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

  1987cited by this paper
• Microinjection of transforming ras protein induces c-fos expression

  1987cited by this paper
• Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells.

  1987cited by this paper
• Participation of c-myc protein in DNA synthesis of human cells.

  1986cited by this paper
• Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.

  1986cited by this paper
• Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation.

  1985cited by this paper
• AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA

  1985cited by this paper
• Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

  1982cited by this paper

• Repression of c-myc Is Necessary but Not Sufficient for Terminal Differentiation of B Lymphocytes In Vitro

  2000cites this paper